Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;63(2):440-450.
doi: 10.1111/epi.17153. Epub 2021 Dec 20.

Association between antiseizure medications and quality of life in epilepsy: A mediation analysis

Meng Wang  1   2 , Kevin Perera  3 , Colin B Josephson  1   2 , Mubasiru Lamidi  1 , Oluwaseyi A Lawal  1 , Oluwagbohunmi Awosoga  4 , Pamela Roach  1   5 , Scott B Patten  1   2   6 , Samuel Wiebe  1   2 , Tolulope T Sajobi  1   2
Affiliations

Association between antiseizure medications and quality of life in epilepsy: A mediation analysis

Meng Wang et al. Epilepsia. 2022 Feb.

Abstract

Objective: The relationship between antiseizure medications (ASMs), which improve health outcomes by controlling seizures, and health-related quality of life (HRQOL) is poorly understood and may involve intermediate variables. We evaluated the potential mediators of the association between ASMs and HRQOL.

Methods: Data are from an outpatient registry of adult patients with epilepsy seen at the Foothills Medical Center, Calgary, Alberta, Canada. Quality of life was measured using the 10-item Quality of Life in Epilepsy, and depression was measured using the Neurological Disorders Depression Inventory for Epilepsy. Propensity score matching was used to adjust for covariate imbalance between patients who received a single ASM (monotherapy) and those who received two or more ASMs (polytherapy) due to confounding. Mediation analysis was used to estimate the mediating effects of depression and ASM side effects on the association between patients' ASM polytherapy and HRQOL.

Results: Of 778 patients included in this analysis, 274 (35.2%) were on two or more ASMs. Patient-reported depression and ASM side effects jointly mediated the association between ASMs and HRQOL; these mediators accounted for 42% of the total average effect of ASM polytherapy ( β = -13.6, 95% confidence interval = -18.2 to -8.6) on HRQOL.

Significance: These findings highlight the importance of managing depression and ASM side effects for improving health outcomes of patients requiring treatment with ASMs. Intervention programs aimed at improving HRQOL of patients with epilepsy need to target these potential mediators.

Keywords: QOLIE10; antiseizure medications; epilepsy; health-related quality of life; mediation analysis.

PubMed Disclaimer

References

REFERENCES

    1. Reynolds EH. The ILAE/IBE/WHO epilepsy global campaign history. Epilepsia. 2002;43(s6):9-11.
    1. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223.
    1. Gholami A, Salarilak S, Lotfabadi P, Kiani F, Rajabi A, Mansori K, et al. Quality of life in epileptic patients compared with healthy people. Med J Islam Repub Iran. 2016;30:388.
    1. Fiest KM, Birbeck GL, Jacoby A, Jette N. Stigma in epilepsy. Curr Neurol Neurosci Rep. 2014;14(5):444.
    1. Begley CE, Beghi E. The economic cost of epilepsy: a review of the literature. Epilepsia. 2002;43(s4):3-9.

Substances